A pharmaceutical company prices a life-saving drug beyond the reach of patients in developing countries where it operates. Under a responsible business conduct framework, this situation most directly implicates:
-
A
Environmental due diligence requirements under ISO 14001
-
B
The right to health as a human right that businesses are expected to respect
-
C
Antitrust and competition law violations under OECD guidelines
-
D
Fiduciary duties owed to shareholders under corporate governance codes